Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

A 10-Week Efficacy and Safety Study for of Gabitril in the Treatment of Adults With Generalized Anxiety Disorder

ClinicalTrials.gov ID: NCT00236054

Public ClinicalTrials.gov record NCT00236054. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 12:45 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A 10-Week, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Flexible-Dosage Study to Evaluate the Efficacy and Safety of Gabitril (up to 16 mg/Day) in the Treatment of Adults With Generalized Anxiety Disorder

Study identification

NCT ID
NCT00236054
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Cephalon
Industry
Enrollment
440 participants

Conditions and interventions

Interventions

  • Gabitril Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 64 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 30, 2004
Primary completion
Not listed
Completion
Nov 30, 2005
Last update posted
May 8, 2014

2004 – 2005

United States locations

U.S. sites
19
U.S. states
12
U.S. cities
17
Facility City State ZIP Site status
Pacific Institute for Medical Research, Inc. Los Angeles California 90024
Pharmacology Research Institute Newport Beach California 92660
Affiliated Research Institute San Diego California 92108
Health Quest Clinical Trials San Diego California 92123
Pacific Clinical Research Medical Group Upland California 91786
UF Behavioral Health Clinic Jacksonville Florida 32257
Janus Center for Psychiatric Research West Palm Beach Florida 33407
Atlanta Institute of Medicine & Research - Atlanta Clinic Atlanta Georgia 30328
Cunningham Clinical Research, LLC Edwardsville Illinois 62025
LSUHSC Anxiety and Mood Disorders Clinic New Orleans Louisiana 70115
Summit Research Network Farmington Hills Michigan 48336
Social Psychiatry Research Inst. Brooklyn New York 11235
Eastside Comprehensive Medical Center New York New York 10021
Medical and Behavioral Health Research, PC New York New York 10023
Hartford Research Group Ltd. Cincinnati Ohio 45242
Oregon Center for Clinical Investigations, Inc. Salem Oregon 97301
South East Health Consultants, LLC Charleston South Carolina 29407
Northwest Clinical Research Center Bellevue Washington 98004
Northbrooke Research Brown Deer Wisconsin 53223

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00236054, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 8, 2014 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00236054 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →